Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

PaperCitations, authors & open-access status

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,270 citations, 2010 year and closed oa status.

1,270
Citations
2010
Year
closed
OA Status

Related on ScholarIQ

W. Eiermann
Author
The Lancet
Journal
HER2/EGFR in Cancer Research
Topic
HER2/EGFR in Cancer Research
Topic
Breast Cancer Treatment Studies
Topic
Breast Lesions and Carcinomas
Topic
470M+ articles · free account